| GlaxoSmithKline AG - Wellvone, Suspension | | 53563 | | 01 | | Wellvone | | Suspension | | P01AX06 | | Atovaquon | | 29.05.1996 | | |
| | Zusammensetzung | | atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml. | | Packungsbestandteile | | Suspension | | | | | | | | Wirkstoffe | Stärke |
|---|
| Atovaquon | 750mg / 5ml |
| | BAG: Wirkstoffe | Stärke |
|---|
| Atovaquon | 750 mg |
| | | | Hilfsstoffe | Stärke |
|---|
| | | | Alcohol Benzylicus | 0.66mg / 5ml | | | | | Aqua Purificata | | | | | | | | | | | | Poloxamer | 188 | | Propylenglycol | | | | | | Vanillin | | | | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 015 | 210 ml | 432.15 | 486.40 | A | SL | Nein |
|
|
